Generics -


Current filters:

Popular Filters

176 to 200 of 1237 results

Teva gains favorable court ruling in Azilect patent case

Teva gains favorable court ruling in Azilect patent case


Israel-based Teva Pharmaceutical Industries has gained a favorable ruling in its patent infringement…

AzilectGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaTeva Pharmaceutical Industries

Australia needs policies that increase generic medicine use


Australia’s Generic Medicines Industry Association strongly refutes claims by the Consumer Health Forum…

Asia-PacificGenericsMarkets & MarketingPolitics

US generics industry files Citizen Petition on biosimilar naming


The USA’s Generic Pharmaceutical Association (GPhA) has filed an official Citizen Petition with the…

GenericsNorth AmericaRegulation

Philippines Food and Drug Administration promotes generics medicine


The Philippines Department of Health Foods and Drugs Administration (PFDA) today launched the Generics…


Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market


Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

US FDA approves first generic Xeloda for colorectal and breast cancers


The US Food and Drug Administration approved the first generic version of Swiss drug major Roche's (ROG:…

capecitabineGenericsNorth AmericaOncologyRegulationRocheTeva Pharmaceutical IndustriesXeloda

Promising outcome of EU platform on access to medicines in Africa


The Platform on Access to Medicines in Developing Countries with a Focus on Africa took a step forward…

EuropeFinancialGenericsHealthcarePharmaceuticalRest of the World

Ban on FDA-regulated drugs from Ranbaxy's Mohali plant


There was another blow for India's largest drugmaker Ranbaxy Laboratories (BSE: 500359) yesterday (September…

Asia-PacificDaiichi SankyoGenericsNorth AmericaProductionRanbaxy LaboratoriesRegulation

Increase of Japan's medical expenditure slowed to 1.7% in 2012


The Japanese Ministry of Health, Labor and Welfare (MHLW) reported approximate medical expenditure (AME)…


Clawback taxation mechanism for generic drugs changes planned for Romania


By year-end, the government of Romania will draw up new legislation that changes the clawback taxation…


Canada's Health Minister sets out plan to help reduce impact of drug shortages


A national protocol for the public notification of drug shortages and a toolkit that identifies steps…

GenericsHealthcareNorth AmericaPharmaceuticalRegulation

Generics market in Southeast Asia set for growth


With its fast-growing, young population and uninsured majority in Southeast Asia, countries in the region…

Asia-PacificGenericsMarkets & MarketingPricingRegulation

Advance Pharmaceutical to invest $25 million in building plant in Russia


USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility…

Advance PharmaceuticalEuropeFinancialGenericsPharmaceuticalProduction

Adcock Ingram agrees takeover terms with CFR


Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

UK lags behind some European countries in biosimilars uptake, new study finds


New research has shown that the UK lags behind some European countries in terms of biosimilars uptake,…

CellTrionepoetinEuropeFilgrastimGenericsHealthcareinfliximabJohnson & JohnsonRemsima

EGA welcomes first biosimilar MAb approvals in Europe


Following the European Medicines Agency's CHMP recommendation, the European Commission (EC) has just…


First biosimilar monoclonal antibody approved in Europe


US injectables and infusion technologies firm Hospira (NYSE: HSP) says the European Commission has approved…

Anti-Arthritics/RheumaticsBiotechnologyCellTrionEuropeGenericsHospiraInflectraMerck & CoRemicadeResearch

Japan's MHLW to expand program on educating patients on cost of branded drugs


The Japanese Ministry of Health, Labor and Welfare (MHLW) plans to expand a program to notify patients…


Avanir Pharma patent settlement with Wockhardt


USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Ireland's HSE announces preferred ACE inhibitor and ARBs


Ireland Health Service Executive's (HSE) Medicines Management Program (MMP) has identified two new preferred…


Final approval for California's SB 598 Biosimilars Bill


A bill updating US State of California's pharmacy substitution law to allow greater patient access to…

BiotechnologyGenericsLegalNorth AmericaRegulation

Bayer in settlement over Cipro pricing


A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

176 to 200 of 1237 results

Company Spotlight



Back to top